R&D Systems™ Recombinant Human CD25/IL-2R alpha Fc Chimera Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Supplier:  R&D Systems™ 1020RL050

Catalog No. 1020RL050

Description

The Recombinant Human CD25/IL-2 R alpha Fc Chimera Protein is derived from NS0. The Recombinant Human CD25/IL-2 R alpha Fc Chimera Protein has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
• Molecular Weight (g/mol): 48.3 kDa (monomer)
• Quantity: 50μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Conjugate: Unconjugated
• Purity or Quality Grade: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

• Gene ID (Entrez): 3559
• Name: CD25/IL-2R alpha
• Source: Mouse myeloma cell line,NS0-derived human CD25/IL-2 R alpha protein, (N-terminus) Human CD25/IL-2 R alpha (Glu22-Cys213) Accession &Num; Q5W007 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Structural Form: Disulfide-linked homodimer
• Recombinant: Recombinant